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Lower extremity bypass is most commonly performed for the treatment of critical limb ischemia. These patients often
pose high surgical risk secondary to signiﬁcant clinical comorbidities. These risks may be compounded when general
anesthesia is considered. We present the case of a patient at high anesthesia risk with critical limb ischemia who was unable
to receive general anesthesia or neuraxial blockade. An infrainguinal bypass was performed using tumescent anesthesia
with minimal intravenous sedation. The patient was discharged 6 days later, and his postoperative course was complicated
by a groin lymphocele. Tumescent local anesthesia is a possible alternative pain management strategy for patients un-
dergoing lower extremity bypass surgery. (J Vasc Surg Cases 2016;2:43-5.)Lower extremity bypass is most commonly performed
to treat critical limb ischemia (CLI).1 These patients are
often high-risk clinical candidates who present challenges
in operative planning, particularly in regard to anesthesia.2
The technique of tumescent local anesthesia (TLA) in-
volves injecting large volumes of dilute local anesthetic in
a subcutaneous plane. Originally developed for liposuction,
TLA is commonly used by vascular surgeons to provide
analgesia during venous ablative procedures.3
We report a case of a patient at high anesthesia risk un-
dergoing femoropopliteal bypass under local anesthesia and
TLA with minimal adjunctive sedation. This case demon-
strates several unique advantages of TLA in intraoperative
pain management in CLI patients who are poor candidates
for traditional methods of anesthesia. Consent was ob-
tained from the patient for publication of relevant personal
data.
CASE REPORT
An 80-year-old man presented to our clinic with a history of
insulin-dependent diabetes mellitus, aortic valve replacement,
congestive heart failure with automatic implantable cardioverter-
deﬁbrillator, chronic obstructive pulmonary disease, chronic
kidney disease stage 4, and atrial ﬁbrillation. His coronary artery
disease was extensive, with several myocardial infarctions in the
past, and he was now status post coronary bypass of two vessels.
He presented with rest pain in his left leg and progressive third
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occlusion of his superﬁcial femoral artery (SFA) with above-knee
popliteal reconstitution along with stenotic one-vessel runoff to
the foot through the anterior tibial artery. Several attempts were
made at endovascular revascularization under local anesthesia,
but they were unsuccessful. On the ﬁrst attempt, the long-
segment SFA occlusion was unable to be crossed; and on the sec-
ond attempt, the wire was unable to re-enter the lumen (Fig 1).
Because of the patient’s rest pain and tissue loss, surgical bypass
of the occluded SFA segment was offered.
The patient was considered at high risk for general anesthesia
secondary to his signiﬁcant cardiopulmonary comorbidities. A neu-
raxial block was considered, but the patient’s concomitant use of
warfarin for atrial ﬁbrillation and mechanical aortic valve and the
resulting elevated international normalized ratio precluded safe
administration or discontinuation of anticoagulation, per institu-
tional protocol. General anesthesia had been considered; however,
recent echocardiography revealed an ejection fraction of 20%,
severe pulmonary hypertension, moderate aortic valvular stenosis,
and moderate decrease in overall left ventricular systolic function
with inferoseptal akinesis. After discussion with the patient, we
proceeded with the bypass using minimal intravenous sedation
and administration of TLA.
Before incision, the patient received 1 mg of midazolam and
25 mcg of fentanyl intravenously. Femoral and popliteal exposures
were performed with focal administration of 1% lidocaine to the
groin and medial thigh soft tissue; 10 mL of 1.5% mepivacaine
was injected directly into the femoral sheath.
Isolated inﬂow and outﬂow lesions were treated by direct
puncture of the femoral and popliteal arteries, respectively. One
external iliac stent was placed, and angioplasty of the anterior tibial
artery was performed before construction of the bypass. Common
femoral endarterectomy was required to establish adequate inﬂow.
As no suitable vein was available, a 6-mm heparin-bonded
polytetraﬂuoroethylene graft was used as a conduit (W. L. Gore
& Associates, Flagstaff, Ariz).
Tumescent adjunct. Before the tunneling of the graft, a
tumescent solution consisting of 40 mL of 1% lidocaine
(10 mg/mL), 40 mL of 0.25% bupivacaine (2.5 mg/mL) with
epinephrine 1:200,000, and 4 mL of 8.4% sodium bicarbonate
(1 mEq/mL) was prepared in 1 liter of normal saline.43
Fig 1. Angiogram demonstrating superﬁcial femoral artery (SFA)
occlusion with above-knee popliteal reconstitution.
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pump (Diomed, Cambridge, UK). Under ultrasound guidance, a
21-gauge spinal needle was used to inﬁltrate the soft tissue and
fascial plane along the sartorius and adductor magnus muscles
(Fig 2). Continuous skip injections were performed from incision
to incision, using the anteromedial intermuscular septum overlyingthe neurovascular bundle containing SFA, femoral vein, and saphe-
nous nerve to landmark the inferior border of inﬁltration. An infu-
sion of dexmethylphenidate at 0.5 mcg/kg/h was brieﬂy initiated
before tumescence administration but was able to be discontinued
immediately after.
A Gore tunneler (W. L. Gore & Associates) was used to pass
the graft through the thigh underneath the fascia lata, through the
adductor canal to the above-knee popliteal artery, unnoticed by
the patient. The bypass was then able to be completed with min-
imal discomfort to the patient. A total of 4 mg of midazolam
and 100 mcg of fentanyl was administered intravenously through
the entirety of the procedure.
The patient was kept on telemetry after the procedure to
monitor for systemic side effects of the local anesthetic. No signiﬁ-
cant changes in hemodynamics were noted. The patient remained
free of signiﬁcant pain postoperatively. On postoperative day 5, he
underwent second and third toe amputation under selective digital
block; he was discharged the next day back on therapeutic-dose
warfarin. The amputation sites remain healed at 6-month follow-up.
DISCUSSION
Many patients undergoing lower extremity bypass for
CLI have signiﬁcant medical comorbidities.4 Perioperative
cardiac complications can occur in 4% to 6% of patients un-
dergoing infrainguinal revascularization under general, spi-
nal, or epidural anesthesia. Barkmeier et al reported a series
of 86 patients undergoing infrainguinal bypass with moni-
tored anesthesia care involving propofol, midazolam, and
fentanyl. During tunneling or any other painful maneuvers,
the dosage of intravenous sedation was increased.5
For patients who are poor candidates for general anes-
thesia, neuraxial block, or heavy sedation, we propose the
addition of TLA. TLA can effectively anesthetize large
areas without reaching toxic plasma concentration. When
diluted in a tumescent preparation, lidocaine has been re-
ported to be safe in doses up to 35 mg/kg.6 In addition
to providing analgesia, TLA produces expansion of the
tunneling plane, which facilitates easier and less traumatic
graft tunneling. Other reports using tumescence have also
suggested that extensive vasoconstriction induced by large
volumes of dilute epinephrine may minimize blood loss
without tachycardia and hypertension.7
Direct administration of mepivacaine to the femoral
sheath provided additional regional anesthesia. Mepiva-
caine is widely used for routine femoral nerve block,
providing anesthesia to the upper thigh and medial leg.8,9
Having broad surgical exposure of the femoral sheath
permitted direct access to the femoral nerve, allowing addi-
tional analgesia along the distribution of the sartorius mus-
cle. The lack of suitable venous conduit necessitated the
use of polytetraﬂuoroethylene, which minimized the need
for extensive incisions and dissection. This may have
contributed to the success of the procedure in regard to
the patient’s comfort and minimal use of intravenous
sedation.
The patient underwent revascularization and amputa-
tion in a staged fashion. Although this could have been per-
formed in a single setting, the gangrene was free of
Fig 2. Ultrasound-guided tumescent injection. A, Soft tissue
inﬁltration with spinal needle. B, Fascial border of adductor
magnus muscle.
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initial presentation, it seemed feasible that the necessary
amputations could be performed with targeted digital
blocks.
CONCLUSIONS
TLA and locoregional anesthesia may be useful ad-
juncts in patients for whom general anesthesia, neuraxial
blockade, or heavy-dose monitored anesthesia care poses
too high a risk. Our case describes a femoropopliteal bypass
performed with minimal intravenous sedation and TLA to
minimize pain, discomfort, and anesthetic exposure. Bypass
with local anesthesia should be reserved for high-risk pa-
tients who can tolerate the length and complexity of the
procedure. Caution should be taken with this approachin patients undergoing reoperative bypass, those with pre-
vious reaction to a local anesthetic, and those who may not
be able to cooperate in maintaining position for the dura-
tion of the procedure. Conversion to general anesthesia
must always be considered as backup.
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